Quick answer: Gut symptoms are common in autism, and research increasingly links the gut microbiome to the gut–brain axis in autistic people. Flore has published one of the field's real datasets: a 2024 pilot open-label study in mSystems showing precision synbiotics improved GI symptoms and gut diversity, plus a microbiome-biomarker model built on 15,249 whole-genome-sequenced profiles. Flore does not sell a probiotic that treats autism — we build a neurobiotic matched to an individual's gut, and we run precision research. This supports gut health; it is not a treatment or cure for autism.

The gut–brain link in autism

GI issues — constipation, diarrhea, reflux, pain — are reported far more often in autistic people than in the general population, and the microbiome sits at the center of that gut–brain relationship. Autistic children frequently show altered gut microbial patterns, and improving GI comfort can meaningfully improve day-to-day wellbeing. That is why a personalized, microbiome-first approach — a psychobiotic made precise — is worth taking seriously.

What Flore's research actually shows

Flore is not a bystander in this science — we contribute the data:

  • A peer-reviewed pilot study. Flore's 2024 paper in mSystems (ASM), “Precision synbiotics increase gut microbiome diversity and improve gastrointestinal symptoms in a pilot open-label study for autism spectrum disorder,” found precision synbiotics increased microbiome diversity and improved GI symptoms. It is a pilot, open-label study — not a randomized controlled trial (RCTs, including The Bright One, are now underway).
  • A microbiome-biomarker model. Flore's autism biomarker work — submitted to The Brain Foundation — was built on 15,249 whole-genome-sequenced microbiome profiles and reached an AUC of 0.936 on a blind 100-sample holdout. This is diagnostics research, not a marketed test, and it points to microbial tryptophan competition (signals such as tnaA and LysDC) as a mechanism.
  • An ongoing precision study. Flore runs an active autism precision research program that families can express interest in — an investigational research study, not a treatment or cure.

We keep the framing honest on purpose: no RCTs completed yet, no bare “success rate” claims, and diagnostic research is clearly separated from the consumer product.

Why precision matters here more than anywhere

Off-the-shelf “autism probiotics” apply one blend to a population that is anything but uniform. Flore's own clustering work shows autistic gut profiles split into distinct groups that respond very differently to intervention — some improve dramatically, others barely at all. Matching strains and prebiotics to an individual's sequenced gut, rather than guessing, is the whole point of a neurobiotic.

Explore Flore's autism precision research
See whether the study is a fit for your family — an investigational research study, not a treatment.
Learn about the study →

Where to start with Flore

For focus and calm, The Calm One ($49, code GOODONETIME15) from GoodOnes™ is a gentle first step. For a formula built from sequenced gut data, the Neurobiome Test is the personalized path. Families interested in the research can express interest in the autism precision study.

Frequently asked questions

Can probiotics treat autism?
No. Probiotics do not treat or cure autism. Research suggests they may support GI comfort and gut health, which matters for wellbeing, but they are not a treatment for autism itself.

What does Flore's research say?
Flore published a 2024 pilot open-label study in mSystems showing precision synbiotics improved GI symptoms and gut diversity, and has built a microbiome-biomarker model on 15,249 sequenced profiles (AUC 0.936). This is research and diagnostics work, not a marketed treatment.

Is there a best probiotic for autism?
There is no single best blend, because autistic gut profiles differ widely and respond differently. Flore matches strains to the individual's sequenced microbiome rather than selling one formula for everyone.